Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
GCO Stock Summary
Top 10 Correlated ETFs
GCO
In the News
Genesco to Report Fourth Quarter Fiscal 2024 Results and Hold Conference Call on March 8, 2024
NASHVILLE, Tenn.--(BUSINESS WIRE)--Genesco will report results for Q4FY24 on March 8, 2024, before the market opens, and hold its conference call at 7:30 a.m. (Central) the same day.
Genesco Inc. to Present at 2024 ICR Conference on January 8, 2024
NASHVILLE, Tenn.--(BUSINESS WIRE)--Genesco Inc. (NYSE: GCO) announced that its management team will present at the 2024 ICR Conference on Monday, January 8, 2024, at 9:30 a.m.
Genesco shares lose significant traction on 3Q earnings drop
Genesco shares plunged nearly 20% Friday afternoon after the company posted a significant year-over-year profit decline. The footwear retail reported earnings of $6.5 million, $0.60 per share, compared to $20.4 million, $1.66 per share, in the year-ago quarter.
Genesco Inc. (GCO) Q3 2024 Earnings Call Transcript
Genesco Inc. (NYSE:GCO ) Q3 2024 Earnings Conference Call December 1, 2023 8:30 AM ET Company Participants Darryl MacQuarrie - Senior Director of FP&A Mimi Vaughn - Board Chair, President and CEO Thomas George - CFO Conference Call Participants Mitchel Kummetz - Seaport Research Mantero Moreno-Cheek - Jefferies Operator Good day, everyone, and welcome to Genesco's Third Quarter Fiscal 2024 Conference Call. Just a reminder, today's call is being recorded.
Genesco (GCO) Misses Q3 Earnings and Revenue Estimates
Genesco (GCO) came out with quarterly earnings of $0.57 per share, missing the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $1.65 per share a year ago.
Should Value Investors Buy Genesco (GCO) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
What Makes Genesco (GCO) a New Strong Buy Stock
Genesco (GCO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Best Value Stocks to Buy for November 29th
TM, GCO and WRB made it to the Zacks Rank #1 (Strong Buy) value stocks list on November 29, 2023.
Best Value Stocks to Buy for November 24th
MOD, AIZ and GCO made it to the Zacks Rank #1 (Strong Buy) value stocks list on November 24, 2023.
Genesco to Report Third Quarter Fiscal 2024 Results and Hold Conference Call on December 1, 2023
NASHVILLE, Tenn.--(BUSINESS WIRE)--Genesco Inc. (NYSE: GCO) today announced that the Company will report results for the third quarter fiscal 2024 on December 1, 2023, before the market opens, and hold its quarterly earnings conference call at 7:30 a.m. (Central Time) the same day. A live audio webcast of the conference call will be available at https://www.genesco.com/investor-relations/news-events/events An audio archive of the call will be available for up to one year at https://www.genesco.
GCO Financial details
GCO Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2024-01-31
Metric | History | 2020-02-01 | 2021-01-30 | 2022-01-29 | 2023-01-28 | 2024-01-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 141.34 | 125.67 | 170.93 | 191.45 | 206.76 | |
Net income per share | 3.95 | -3.94 | 8.11 | 5.77 | -1.5 | |
Operating cash flow per share | 7.54 | 11.1 | 16.93 | -13.24 | 0 | |
Free cash flow per share | 5.62 | 9.4 | 13.12 | -18.05 | 0 | |
Cash per share | 5.24 | 15.13 | 22.62 | 3.85 | 3.13 | |
Book value per share | 39.84 | 39.87 | 42.52 | 48.72 | 50.81 | |
Tangible book value per share | 29.64 | 34.98 | 37.69 | 43.46 | 50.81 | |
Share holders equity per share | 39.84 | 39.87 | 42.52 | 48.72 | 50.81 | |
Interest debt per share | 52.01 | 51.99 | 44.82 | 46.83 | 15.27 | |
Market cap | 611.19M | 551.72M | 891.86M | 594.95M | 312.33M | |
Enterprise value | 1.33B | 1.07B | 1.2B | 1.13B | 800.12M | |
P/E ratio | 9.96 | -9.85 | 7.77 | 8.27 | -18.56 | |
Price to sales ratio | 0.28 | 0.31 | 0.37 | 0.25 | 0.13 | |
POCF ratio | 5.22 | 3.5 | 3.72 | -3.61 | 0 | |
PFCF ratio | 6.99 | 4.13 | 4.8 | -2.65 | 0 | |
P/B Ratio | 0.99 | 0.97 | 1.48 | 0.98 | 0.55 | |
PTB ratio | 0.99 | 0.97 | 1.48 | 0.98 | 0.55 | |
EV to sales | 0.61 | 0.6 | 0.5 | 0.47 | 0.34 | |
Enterprise value over EBITDA | 12.13 | 12.08 | 8.17 | 12.01 | 33.93 | |
EV to operating cash flow | 11.39 | 6.79 | 5.02 | -6.84 | 0 | |
EV to free cash flow | 15.27 | 8.01 | 6.47 | -5.01 | 0 | |
Earnings yield | 0.1 | -0.1 | 0.13 | 0.12 | -0.05 | |
Free cash flow yield | 0.14 | 0.24 | 0.21 | -0.38 | 0 | |
Debt to equity | 1.3 | 1.3 | 1.05 | 0.96 | 0.29 | |
Debt to assets | 0.48 | 0.46 | 0.4 | 0.4 | 0.12 | |
Net debt to EBITDA | 6.57 | 5.86 | 2.12 | 5.67 | 20.69 | |
Current ratio | 1.4 | 1.66 | 1.64 | 1.59 | 1.59 | |
Interest coverage | 18.12 | 8.28 | 42.65 | 17.48 | 2.16 | |
Income quality | 1.91 | -2.8 | 2.09 | -2.29 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.44 | 0.45 | 0.42 | 0.43 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.09 | 0.04 | 0.04 | 0.05 | 0 | |
Capex to operating cash flow | -0.25 | -0.15 | -0.22 | 0.36 | 0 | |
Capex to revenue | -0.01 | -0.01 | -0.02 | -0.03 | 0 | |
Capex to depreciation | -0.6 | -0.52 | -1.25 | -1.4 | 0 | |
Stock based compensation to revenue | 0 | 0.06 | 0 | 0.01 | 0 | |
Graham number | 59.5 | 59.46 | 88.05 | 79.56 | 41.36 | |
ROIC | 0.02 | 0.01 | 0.04 | 0.02 | 0.02 | |
Return on tangible assets | 0.04 | -0.04 | 0.08 | 0.05 | -0.01 | |
Graham Net | -49.87 | -44.77 | -33.2 | -43.5 | -43.92 | |
Working capital | 146.25M | 264.66M | 278.07M | 211.89M | 187.81M | |
Tangible asset value | 460.8M | 497.28M | 534.06M | 541.41M | 571.2M | |
Net current asset value | -552.95M | -353.01M | -249.83M | -276.79M | -251.34M | |
Invested capital | 1.3 | 1.3 | 1.05 | 0.96 | 0.29 | |
Average receivables | 79.71M | 30.3M | 35.46M | 40.16M | 47.22M | |
Average payables | 147.19M | 143.11M | 151.46M | 148.74M | 129.81M | |
Average inventory | 367.05M | 328.12M | 284.58M | 368.11M | 418.49M | |
Days sales outstanding | 4.85 | 6.42 | 5.95 | 6.25 | 8.42 | |
Days payables outstanding | 43.71 | 55.91 | 44.85 | 42.38 | 34.13 | |
Days of inventory on hand | 117.57 | 108.14 | 81.83 | 133.88 | 112.84 | |
Receivables turnover | 75.25 | 56.88 | 61.3 | 58.43 | 43.36 | |
Payables turnover | 8.35 | 6.53 | 8.14 | 8.61 | 10.69 | |
Inventory turnover | 3.1 | 3.38 | 4.46 | 2.73 | 3.23 | |
ROE | 0.1 | -0.1 | 0.19 | 0.12 | -0.03 | |
Capex per share | -1.92 | -1.7 | -3.8 | -4.81 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2024-01-31 for Q4
Metric | History | 2023-01-28 | 2023-04-29 | 2023-07-29 | 2023-10-28 | 2024-01-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 60.85 | 40.97 | 46.13 | 53.16 | 67.73 | |
Net income per share | 3.27 | -1.6 | -2.79 | 0.6 | 2.49 | |
Operating cash flow per share | 6.64 | -5.12 | 3.11 | 0.15 | 0 | |
Free cash flow per share | 4.95 | -6.58 | 1.52 | -1.18 | 0 | |
Cash per share | 4.03 | 2.69 | 3.3 | 1.99 | 3.22 | |
Book value per share | 50.95 | 49.39 | 47.01 | 49.27 | 52.35 | |
Tangible book value per share | 45.44 | 43.84 | 43.69 | 45.99 | 52.35 | |
Share holders equity per share | 50.95 | 49.39 | 47.01 | 49.27 | 52.35 | |
Interest debt per share | 48.83 | 55.18 | 59.51 | 59.88 | 15.16 | |
Market cap | 569.01M | 408.88M | 314.62M | 282.37M | 303.11M | |
Enterprise value | 1.1B | 1.03B | 949.53M | 911.04M | 790.9M | |
P/E ratio | 3.65 | -5.42 | -2.48 | 10.8 | 2.79 | |
Price to sales ratio | 0.78 | 0.85 | 0.6 | 0.49 | 0.41 | |
POCF ratio | 7.19 | -6.76 | 8.91 | 177.03 | 0 | |
PFCF ratio | 9.64 | -5.26 | 18.24 | -21.98 | 0 | |
P/B Ratio | 0.94 | 0.7 | 0.59 | 0.53 | 0.53 | |
PTB ratio | 0.94 | 0.7 | 0.59 | 0.53 | 0.53 | |
EV to sales | 1.52 | 2.12 | 1.82 | 1.57 | 1.07 | |
Enterprise value over EBITDA | 21.68 | -45.06 | -93.57 | 84.33 | 17.41 | |
EV to operating cash flow | 13.93 | -16.98 | 26.89 | 571.18 | 0 | |
EV to free cash flow | 18.67 | -13.21 | 55.05 | -70.93 | 0 | |
Earnings yield | 0.07 | -0.05 | -0.1 | 0.02 | 0.09 | |
Free cash flow yield | 0.1 | -0.19 | 0.05 | -0.05 | 0 | |
Debt to equity | 0.96 | 1.11 | 1.26 | 1.21 | 0.29 | |
Debt to assets | 0.4 | 0.43 | 0.45 | 0.44 | 0.12 | |
Net debt to EBITDA | 10.48 | -27.11 | -62.57 | 58.19 | 10.74 | |
Current ratio | 1.59 | 1.7 | 1.63 | 1.61 | 1.59 | |
Interest coverage | 37.99 | -13.93 | -16.21 | 4.92 | 25.08 | |
Income quality | 2.03 | 3.2 | -1.12 | 0.24 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.39 | 0.51 | 0.49 | 0.46 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.05 | 0.04 | 0.03 | 0.02 | 0 | |
Capex to operating cash flow | -0.25 | 0.29 | -0.51 | -9.05 | 0 | |
Capex to revenue | -0.03 | -0.04 | -0.03 | -0.02 | 0 | |
Capex to depreciation | -1.84 | -1.53 | -1.53 | -1.17 | 0 | |
Stock based compensation to revenue | 0 | 0.01 | 0.01 | 0.01 | 0 | |
Graham number | 61.22 | 42.17 | 54.35 | 25.79 | 54.18 | |
ROIC | 0.02 | -0.01 | -0.02 | 0 | 0.02 | |
Return on tangible assets | 0.03 | -0.01 | -0.02 | 0 | 0.02 | |
Graham Net | -45.48 | -51.28 | -56.54 | -58.1 | -45.26 | |
Working capital | 211.89M | 247.31M | 242.29M | 241.55M | 187.81M | |
Tangible asset value | 541.41M | 517.16M | 495.35M | 501.23M | 571.2M | |
Net current asset value | -276.79M | -313.75M | -336.87M | -317.26M | -251.34M | |
Invested capital | 0.96 | 1.11 | 1.26 | 1.21 | 0.29 | |
Average receivables | 44.74M | 47.44M | 52.21M | 53.64M | 55.28M | |
Average payables | 184.2M | 144.41M | 155.16M | 176.59M | 150.65M | |
Average inventory | 510.75M | 464.39M | 480.94M | 503.93M | 447.85M | |
Days sales outstanding | 5.07 | 10.07 | 8.66 | 8.85 | 6.53 | |
Days payables outstanding | 33.6 | 50.85 | 54.79 | 55.84 | 25.99 | |
Days of inventory on hand | 106.13 | 166.46 | 161.61 | 154.56 | 85.94 | |
Receivables turnover | 17.76 | 8.94 | 10.39 | 10.18 | 13.78 | |
Payables turnover | 2.68 | 1.77 | 1.64 | 1.61 | 3.46 | |
Inventory turnover | 0.85 | 0.54 | 0.56 | 0.58 | 1.05 | |
ROE | 0.06 | -0.03 | -0.06 | 0.01 | 0.05 | |
Capex per share | -1.69 | -1.46 | -1.59 | -1.33 | 0 |
GCO Frequently Asked Questions
What is Genesco Inc. stock symbol ?
Genesco Inc. is a US stock , located in Nashville of Tn and trading under the symbol GCO
What is Genesco Inc. stock quote today ?
Genesco Inc. stock price is $28.14 today.
Is Genesco Inc. stock public?
Yes, Genesco Inc. is a publicly traded company.